EQUAPELL Trademark
Serial Number: 79255931 • Registration: 6004576
EQUAPELL is a trademark filed by
RN Laboratories AG
on February 7, 2019. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Trademark Details
Filing Date
February 7, 2019
Registration Date
March 10, 2020
Published for Opposition
July 23, 2019
Goods & Services
Cosmetic products for skin treatment and care, namely cosmetic preparations for skin treatment and care
Chemical products for scientific use, namely, chemical preparations for the manufacture of cosmetics
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 16, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 21, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 21, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 10, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jan 30, 2020 ETOP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Dec 19, 2019 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Dec 6, 2019 LIMG
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 21, 2019 ETOF
PUBLISHED FOR OPPOSITION
Jul 23, 2019 PUBO
NOTICE OF PUBLICATION
Jul 3, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 8, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 17, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 17, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 25, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 24, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 4, 2019 REPR
